首页> 美国卫生研究院文献>Redox Biology >S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension
【2h】

S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension

机译:S-亚硝化损害肺动脉高压中的KLF4活性并刺激内皮功能障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Krüppel-like factor 4 (KLF4) is a transcription factor with conserved zinc finger domains. As an essential regulator of vascular homeostasis, KLF4 exerts a protective effect in endothelial cells (ECs), including regulating vasodilation, inflammation, coagulation and oxidative stress. However, the underlying mechanisms modifying KLF4 activity in mediating vascular function remain poorly understood. Recently, essential roles for S-nitrosation have been implicated in many pathophysiologic processes of cardiovascular disease. Here, we demonstrated that KLF4 could undergo S-nitrosation in response to nitrosative stress in ECs, leading to the decreased nuclear localization with compromised transactivity. Mass-spectrometry and site-directed mutagenesis revealed that S-nitrosation modified KLF4 predominantly at Cys437. Functionally, KLF4 dependent vasodilatory response was impaired after S-nitrosoglutathione (GSNO) treatment. In ECs, endothelin-1 (ET-1) induced KLF4 S-nitrosation, which was inhibited by an endothelin receptor antagonist Bosentan. In hypoxia-induced rat model of pulmonary arterial hypertension (PAH), S-nitrosated KLF4 (SNO-KLF4) was significantly increased in lung tissues, along with decreased nuclear localization of KLF4. In summary, we demonstrated that S-nitrosation is a novel mechanism for the post-translational modification of KLF4 in ECs. Moreover, these findings suggested that KLF4 S-nitrosation may be implicated in the pathogenesis of vascular dysfunction and diseases such as PAH.
机译:Krüppel样因子4(KLF4)是具有保守锌指结构域的转录因子。作为血管稳态的重要调节剂,KLF4在内皮细胞(EC)中发挥保护作用,包括调节血管舒张,炎症,凝血和氧化应激。然而,在介导血管功能中修饰KLF4活性的潜在机制仍知之甚少。最近,在心血管疾病的许多病理生理过程中已经涉及到S-亚硝化的重要作用。在这里,我们证明了KLF4可能会响应EC中的亚硝化应激而经历S-亚硝化,从而导致核定位的降低和交易活性的降低。质谱和定点诱变显示,S-亚硝化作用主要在Cys437处修饰KLF4。在功能上,S-亚硝基谷胱甘肽(GSNO)治疗后,KLF4依赖的血管舒张反应受损。在EC中,内皮素-1(ET-1)诱导KLF4 S亚硝化,内皮素受体拮抗剂波生坦抑制了该作用。在低氧诱导的大鼠肺动脉高压(PAH)模型中,肺组织中S亚硝化KLF4(SNO-KLF4)显着增加,同时KLF4的核定位降低。总之,我们证明了S-亚硝基化是EC中KLF4的翻译后修饰的一种新机制。此外,这些发现表明,KLF4 S-亚硝化作用可能与血管功能障碍和PAH等疾病的发病机制有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号